Showing results (3171-3180 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 14, 2009
Antipsychotic medication: the potential role of 5-HT(1A) receptor agonismAndrew C McCreary, Caitlin A JonesCurrent Pharmaceutical Design|April 24, 1999
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indicationsJ R McCarthy, S C Heinrichs, D E GrigoriadisCurrent Pharmaceutical Design|April 24, 1999
A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous systemR J Bridges, M P Kavanaugh, A R ChamberlinCurrent Pharmaceutical Design|April 24, 1999
Antagonists selective for NMDA receptors containing the NR2B subunitB L Chenard, F S MennitiCurrent Pharmaceutical Design|September 7, 2000
Treatment of Helicobacter pylori infection in childrenM A GilgerCurrent Pharmaceutical Design|September 7, 2000
Regional pharmacokinetics of orally administered PET tracersA J Fischman, A A Bonab, R H RubinCurrent Pharmaceutical Design|June 1, 2000
Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluationC M Hansen, K J Hamberg, E Binderup, et al.Current Pharmaceutical Design|June 1, 2000
Overview of childhood epilepsy and epileptic syndromes and advances in therapyL D Morton, J M PellockCurrent Pharmaceutical Design|June 1, 2000
Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasisP E Morris, G A OmuraPageof 1,008